Hartmut Ehrlich: CEO of Abivax

from BioBoss · host Hartmut Ehrlich

Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.

Episode metadata supplied by the publisher feed · Published Apr 22, 2023

Embed this episode

Attribution link and audio player

Ready to play

Hartmut Ehrlich: CEO of Abivax

0:00 50:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 50 minutes long.

When was this BioBoss episode published?

This episode was published on April 22, 2023.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!